Midodrine Medical Valley (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrine Medical Valley, is an Alpha-1 adrenergic agonist presented as an oral dosage form for oral administration. Approved in the European Union, it acts as a vasopressor to increase peripheral vascular resistance and raise blood pressure in patients with orthostatic hypotension, thereby reducing dizziness and syncope.

GNH USA supplies Midodrine Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured product availability across global markets with full compliance to EU pharmacopeial standards and traceable batch records.

Midodrine is employed in the management of disorders characterized by inadequate vascular tone and resultant low blood pressure, most notably orthostatic hypotension.

- Orthostatic hypotension: increases standing blood pressure and reduces dizziness or fainting episodes. - Neurogenic orthostatic hypotension: improves vascular tone in patients with autonomic failure, helping maintain upright blood pressure.

Midodrine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Piloerection (goose‑flesh skin) - Pruritus (itching) - Urinary retention - Supine hypertension (elevated blood pressure while lying down) - Headache - Nausea

Serious or Rare Side Effects: - Severe hypertension leading to cardiovascular strain - Bradycardia or arrhythmias - Allergic reactions such as rash or angioedema - Ischemic events in extremities - Chest pain or myocardial ischemia

When prescribing Midodrine, clinicians should consider several safety measures. - Blood pressure monitoring: check supine and standing pressures to avoid excessive hypertension. - Cardiovascular disease: use cautiously in patients with coronary artery disease or heart failure. - Renal impairment: dose adjustment may be needed in severe renal dysfunction. - Concomitant antihypertensives: monitor for additive blood‑pressure‑lowering effects. - Pregnancy and lactation: safety not established; weigh potential benefits against risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Midodrine can interact with other medicines that affect blood pressure or adrenergic pathways.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other vasopressors or alpha‑agonists: additive pressor effects.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance orthostatic hypotension when therapy is stopped. - Antihypertensive agents (ACE inhibitors, beta‑blockers): may blunt desired pressor response. - Tricyclic antidepressants: potential for increased blood pressure. - SSRIs or SNRIs: monitor for unexpected blood‑pressure changes.